Carol Giltner Gallagher, Director at Atara Biotherapeutics, holds 629.61K shares in Atara Biotherapeutics (Ticker: ATRA), holds ― shares in AnaptysBio (Ticker: ANAB), holds 31.93K shares in Tempest Therapeutics (Ticker: TPST).
What was Carol Giltner Gallagher’s latest transaction?
Carol Giltner Gallagher latest transaction was an Uninformative Buy of ―.
What was Carol Giltner Gallagher's most profitable transaction?
Carol Giltner Gallagher’s most profitable transaction was an Informative Buy of ATRA stock on October 23, 2014. The return on the trade was 254.40%.
What is Carol Giltner Gallagher's role in Atara Biotherapeutics?
Carol Giltner Gallagher's role in Atara Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.